This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock | The Motley Fool
Novo Nordisk recently announced promising trial results for one of its GLP-1 drugs in development.

Source: The Motley Fool
Novo Nordisk recently announced promising trial results for one of its GLP-1 drugs in development.